top of page

Dr. Lee Unveils Qualia Oto Technologies at the 2024 North Texas Cochlear Implant Symposium

The Callier Center’s biannual symposium welcomed Qualia Oto's presentation on the novel advancements of cochlear implant technologies.


Dr. Kenneth Lee (MD-PhD), CMO of Qualia Oto and Medical Director of the UT Southwestern Pediatric Group, was an invited speaker at the 2024 Symposium.

May 9, 2023 – The Callier Center for Communication Disorders hosted its biannual North Texas Cochlear Implant Symposium last Friday, May 3rd, featuring physicians, audiologists, and professors from UT Southwestern and UT Dallas, as well as international otolaryngologist Dr. Sharon Cushing from the University of Toronto.


Qualia Oto’s co-founder and Chief Medical Officer Dr. Kenneth Lee took the stage to present the company’s precise application of its unique polymer technology within cochlear implant development, capable of improving the lives of individuals needing implantation; he will share Qualia Oto’s work on the international stage this summer at the American Cochlear Implant Alliance conference in Vancouver.


“By incorporating Qualia Oto’s innovative polymer science with cochlear implants, we propose a novel strategy that allows insertion of the array with minimal trauma and ultimate positioning of the electrodes in an optimal intra-cochlear location,” noted Dr. Lee. “The North Texas CI Symposium allowed us to publicly share the advancements we have been making for years. I will expand on this talk at ACIA’s CI2024 in Vancouver in July to globally showcase our capabilities, and we anticipate much excitement from both industry leaders and hearing health professionals worldwide.”


Dr. Lee did a fantastic job explaining the fundamental science, highlighting its advantages, and discussing corresponding data, although the videos presenting Qualia Oto’s technologies were perhaps the most memorable.


“We all know the phrase ‘a picture is worth a thousand words’; it is estimated that a one-minute video is worth 1.8 million words,” COO Benedict Voit noted. “No matter how well I describe our materials and their capabilities, there’s really nothing like seeing our shape-adaptive polymers in action. Incorporating our proprietary technology into cochlear implant design and manufacturing over the coming years will be a game changer.”


Dr. Andrea Warner-Czyz, the current Chair of the Board of Directors for the American Cochlear Implant Alliance, also attended the Symposium. She is excited about the potential offered by Qualia Oto’s innovations, and she expects Dr. Lee’s presentation at CI2024 will spark great interest:


“Dr. Lee’s presentation showcased the implementation of new polymer science in the cochlear implant field. Qualia Oto’s technology has the potential to transform the accuracy of internal device placement and rate of hearing preservation, both of which will benefit the next generation of cochlear implant users. I look forward to Dr. Lee’s talk and the discussion it will inspire at the international ACI Alliance conference in July.”


The North Texas Cochlear Implant Symposium had a great turnout, with several hundred attendees, and Qualia Oto would like to thank the Callier Center, with special recognition to the symposium’s course directors Melissa Sweeney and Dr. Walter Kutz, and Callier Center’s Executive Director Dr. Angela Shoup.


Qualia Oto looks forward to the ACIA conference, which will push the company into the global spotlight. As an internationally recognized event, CI24 expects more than 1,000 attendees including leaders in the cochlear space, as well as industry giants Advanced Bionics, Cochlear, and MED-EL.



About Qualia Oto

Qualia Oto is an innovative biomedical device company focused on improving the individual’s quality of life through better aural technologies. By integrating our proprietary shape-adaptive polymers, we are advancing the next generation of cochlear implants allowing for minimal trauma, a superior positioning of electrodes, and an increased effectiveness and stimulatory resolution for chronic, targeted microstimulation. Qualia Oto’s team of medical and scientific experts aim to reshape – literally and figuratively – cochlear implants and their capacity in overcoming debilitating hearing loss.


For additional information, please contact:

Benedict Voit, Chief Operating Officer


Comments


bottom of page